Skip to main content

Dr. Spagnoli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Spagnoli's full profile

Already have an account?

  • Office

    1725 W Harrison St
    Ste 718
    Chicago, IL 60612
    Phone+1 312-942-3034
    Fax+1 312-942-4168

Summary

  • Dr. Anna Spagnoli is a Pediatric Endocrinology specialist based in Chicago, IL. She completed her fellowship in Pediatric Endocrinology from 1995 to 1999 at Oregon Health & Science University and graduated in 1982 from University of Rome Tor Vergata. She has been published several times, with an array of publications spanning from 2018 to 2023. Her work has focused on a variety of topics including bone homeostasis, tissue engineering, osteoarthritis, and interorgan interactions regarding aging. She is recognized for her research in these fields and her work has informed other publications.

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Endocrinology, 1995 - 1999
  • Other
    OtherClass of 1982

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1999 - Present
  • IL State Medical License
    IL State Medical License 2015 - 2026
  • NE State Medical License
    NE State Medical License 2018 - 2021
  • NC State Medical License
    NC State Medical License 2007 - 2016
  • TN State Medical License
    TN State Medical License 2001 - 2009
  • American Board of Pediatrics Pediatric Endocrinology

Publications & Presentations

PubMed

Press Mentions

  • Child Health Research Institute Outlines Goals, Thanks Benefactors
    Child Health Research Institute Outlines Goals, Thanks BenefactorsJuly 24th, 2019
  • Potential Disease-Modifying Drug for Osteoarthritis Identified
    Potential Disease-Modifying Drug for Osteoarthritis IdentifiedMay 15th, 2019